Cancer Advances, Inc. (CancerAdvances)

Oncology Corporate Profile

HQ Location

4364 South Alston Avenue, Suite 210
Durham, NC 27713

Company Description

Cancer Advances Inc., a wholly owned subsidiary of Cato Holding Company, is a biotechnology company focused on impacting human health and suppressing the progression of gastrointestinal cancers by enhancing the adaptive immune system.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
G17DTpolyclonal antibody stimulatorGastric cancerIII
G17DTpolyclonal antibody stimulatorPancreatic cancerIII
G17DTpolyclonal antibody stimulatorColorectal cancerII

View additional information on product candidates here »


Recent News Headlines

There are no news items to display